Journal Global Drugs and Therapeutics (Glob Drug Ther) (ISSN 2733-256X)

Aims and Scope

Global Drugs and Therapeutics is a multidisciplinary journal yielding a great benefit to the medical community and the society. The journal includes studies including dosage forms, controlled release, drug absorption, ADMET, bioavailability, Nano medicine, Gene based delivery and therapy, drug designing and delivery, long term and short-term impact of specific delivery issues, associated disease scenario, relation of drug delivery and diseases. It covers a vast area of topics such as Medicinal Organic Chemistry, Synthetic Medicinal chemistry, Medicinal Biochemistry, Medicinal Chemical Research, Medicinal Companies and Market Analysis, Applied Medicinal chemistry, Bioorganic Chemistry, Chemical Pharmacology, Chemical Biology of Molecules, Anti-Allergic, Anti-Infective Agents in Medicinal chemistry, pharmaceutical chemistry, Chemistry, Pharmacoanalysis, Pharmaceutical manufacturing. Papers published in Global Drugs and Therapeutics should have in depth knowledge in the area of medicine and treatment and should deliver important medical advances.

All the work at Science Repository is licensed under a Creative Commons Attribution 4.0 International License. Authors at Science Repository retain copyright to their work and allow others to copy, distribute, transmit, and adapt their work, provided proper attribution is given.

   
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. View License Deed | View Legal Code

For submission authors can directly submit manuscript to articles@sciencerepository.org

Manuscripts number will be provided to the corresponding author within 72 hours for the respective manuscript submitted.

• 14 day review process with international peer-review standards
• Timeline of processing from Submission to Publication is 30 days
• Manuscript will be published within 7 days of acceptance

In Press Volume 2, Issue 1

Editor-in-chief

EL HASSANE LARHRIB

Senior lecturer in Pharmaceutics

Department of Pharmacy

University of Huddersfield

United Kingdom

Biography

Dr. Larhrib was educated at the University of Sciences and Technology, Lille I and the faculty of Pharmacy, Lille II, France where he obtained an MSc Biochem, DU Pharm, DESS Pharm. Tech. and a certificate in Pharm. Chemistry. He moved to the UK to do a PhD in Pharmaceutical technology at Liverpool John Moores University, using high speed compaction simulator to fundamentally study the mechanism of compaction of pharmaceutical powders under the supervision of Dr. James Wells and Prof. Mike Rubinstein (1994-1998). Following his PhD, Dr Larhrib worked for 4 years (1998-2002) as Senior Research Fellow in Pharmaceutics at the Department of Pharmacy, King’s College London. He worked at Liverpool John Moores University as a Senior lecturer in Pharmaceutics for 6 years (2002-2007) before joining the industry; Solid Solution Limited, Liverpool (2007-2010). He was involved in cosmetic products development and manufacture. He moved to Medway school of Pharmacy before joining the University of Huddersfield as a Senior lecturer in Pharmaceutics in July 2011. Dr. Larhrib is a regular reviewer for many international Pharmaceutical journals and member of editorial board of journal of International Research in Medical and Pharmaceutical Sciences and British Journal of Pharmaceutical Research.

Editorial board

Current Issue Volume 1, Issue 1

Submit Manuscript

You can submit your manuscript at Science Repository. Authors submit manuscript files and metadata & can request for revision. Editors use the system to review submissions, assign to reviewers, and make and communicate decisions to accept, revise, transfer or reject manuscripts. Reviewers are invited to work on manuscripts, can accept or reject assignments.

For submission authors can directly submit manuscript to articles@sciencerepository.org

Manuscripts number will be provided to the corresponding author within 72 hours for the respective manuscript submitted.

• 14 day review process with international peer-review standards
• Timeline of processing from Submission to Publication is 30 days
• Manuscript will be published within 7 days of acceptance

Publication Charges

Global Drugs and Therapeutics is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License".

In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Global Drugs and Therapeutics are £ (GBP) 1099.

Frequently Asked Questions (FAQs)

Why do we charge?

All articles published in Science Repository are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in Science Repository Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

• Maintain the portal for best experienece
• Recover capitalization cost
• Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development
• Although we charge the minimum possible but we will reduce the publication-charge cost downward over time.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

Who will pay the APC (Article Processing Charges)?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

• Online Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction gateway charges may be levied on the payee.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after processing of the manuscript.

Withdrawal Charges

Please check our Refund Policy

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

For more details you can refer to FAQs or contact us support@sciencerepository.org

Archive